Developer of human gene-based therapies. The company has developed a platform to bring new disease-modifying therapies to patients with severe disorders. The company's pipeline includes gene-based therapies for lipoprotein lipase deficiency, or LPLD, Sanfilippo B, Parkinson's Disease and Hemophilia B.read more
Chris Dandrea ā Vice President, Global Program Management at uniQure
Executive Bio
Chris Dandrea serves as the Vice President, Global Program Management of uniQure. Chris started at uniQure in June of 2018. Chris currently resides in the Greater Boston Area.
Executive Team Culture Ratings from uniQure Employees
TOP
10%
uniQure's Executive Team scores in the Top 10% of similar sized companies on Comparably